News
-
-
PRESS RELEASE
Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem
Wellgistics Health, Inc. announces Q2 2025 operational results, adding 116 new partnerships and expanding its pharmaceutical products and pharmacy network. The company aims to revolutionize drug access and distribution with a modern, AI-powered infrastructure -
-
PRESS RELEASE
Wellgistics Health Joins OptiSource to Expand Access and Drive Savings for Independent Pharmacies
Wellgistics Health joins OptiSource, LLC to enhance purchasing power and support for independent pharmacies. The strategic move boosts access to generics, formulary depth, and specialty items -
-
PRESS RELEASE
Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes
Wellgistics Health, Inc. (NASDAQ:WGRX) announced preliminary inclusion in the Russell 2000 and Russell 3000 Indexes, enhancing visibility and institutional interest. Company redefines medication distribution & fulfillment -
-
PRESS RELEASE
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
Wellgistics Health, Inc. announces strategic leadership appointments and Board addition, reinforcing growth strategy execution and operational excellence to enhance shareholder value -
-
PRESS RELEASE
Wellgistics Health Reports 36% Revenue Growth in Q1 2025 as Manufacturer Access and Pharmacy Onboarding Accelerate
Wellgistics Health, Inc. announces Q1 2025 financial results showcasing revenue growth, strategic expansion, and future momentum. The company redefines pharmaceutical distribution with proprietary technology